Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00059887.xml
CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1807770
DOI: 10.1055/s-0045-1807770
BREAST TUMORS
1817
POSTER PRESENTATION
Immune-related adverse events with (neo)adjuvant pembrolizumab in patients with early-stage triple-negative breast cancer
Publication History
Article published online:
06 May 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil
Bibliographical Record
Isabella Gonçalves Gutierres, Matheus de Oliveira Andrade, Monique Celeste Tavares, Isadora Martins de Sousa, Ana Carolina Marin Comini, Flávia Cavalcanti Balint, Mariana Carvalho Gouveia, José Bines, Fernanda Madasi, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Daniele Assad-Suzuki, Zenaide Silva de Souza, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Maria del Pilar Estevez-Diz, Laura Testa, Romualdo Barroso-Sousa, Renata Colombo Bonadio. Immune-related adverse events with (neo)adjuvant pembrolizumab in patients with early-stage triple-negative breast cancer. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807770
Isabella Gonçalves Gutierres, Matheus de Oliveira Andrade, Monique Celeste Tavares, Isadora Martins de Sousa, Ana Carolina Marin Comini, Flávia Cavalcanti Balint, Mariana Carvalho Gouveia, José Bines, Fernanda Madasi, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Daniele Assad-Suzuki, Zenaide Silva de Souza, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Maria del Pilar Estevez-Diz, Laura Testa, Romualdo Barroso-Sousa, Renata Colombo Bonadio. Immune-related adverse events with (neo)adjuvant pembrolizumab in patients with early-stage triple-negative breast cancer. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1807770